Study on the synthesis of graphene/Fe2O3-TiO2@porphyrin hybrid composite and its application as photocatalyst for dyeing wastewater treatment
Vietnam Journal of Catalysis and Adsorption · 2020
DOI: 10.51316/jca.2020.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vietnam Journal of Catalysis and Adsorption, 2020. Verfasst von Tuan Truong und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Graphene/Fe2O3-TiO2@porphyrin composite was successfully fabricated via self-assembled approach. The synthesized material was fully characterized by UV-Vis, SEM, XRD, photoluminescence, and FT-IR techniques. The graphene@Fe2O3-TiO2@porphyrin composite exhibited uniform incorporation of Fe2O3-TiO2 particles and aggregated nanorod porphyrin on the graphene surface. The resultant graphene@Fe2O3-TiO2@porphyrin composite reveal high photocatalytic performance toward RhB degradation under silmulated sunlight irradiation, which can be utilized as a promising photocatalyst for green environment remediation.
Zitieren
APA
Truong, T., Nguyen, G., Nguyen, P., Phuong, H. H., Hong, P. N. T., Tran, L., & La, D. (2020). Study on the synthesis of graphene/Fe2O3-TiO2@porphyrin hybrid composite and its application as photocatalyst for dyeing wastewater treatment. Vietnam Journal of Catalysis and Adsorption. https://doi.org/10.51316/jca.2020.002
Vancouver
Truong T, Nguyen G, Nguyen P, Phuong HH, Hong PNT, Tran L, et al. Study on the synthesis of graphene/Fe2O3-TiO2@porphyrin hybrid composite and its application as photocatalyst for dyeing wastewater treatment. Vietnam Journal of Catalysis and Adsorption. 2020. doi:10.51316/jca.2020.002
BibTeX
@article{Truong2020,
author = {Truong, Tuan and Nguyen, Giang and Nguyen, Phuong and Phuong, Hien Ho and Hong, Phuong Nguyen Thi and Tran, Lam and La, Duong},
title = {Study on the synthesis of graphene/Fe2O3-TiO2@porphyrin hybrid composite and its application as photocatalyst for dyeing wastewater treatment},
journal = {Vietnam Journal of Catalysis and Adsorption},
year = {2020},
doi = {10.51316/jca.2020.002}
}
EUVIMED